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Urinary tract infection represents one of the most common diseases encountered in medical practice 
today and occurring from the neonate to the geriatric age group. Despite the widespread availability of 
antibiotics, it remains the most common bacterial infection in the human being. A total of 174 urine 
samples were analyzed for isolation and identification, 68 found to be significant bacteriuria with 
Escherichia coli (59%), followed by Pseudomonas aeruginosa (15%), Klebsiella pneumoniae (10%), 
Proteus mirabilis (9%), Staphylococcus aureus (6%) and Citrobacter freundii (1%). The urinary tract 
infections were found to most frequently in female (63%) than male (37%). The isolated uropathogens 
showed resistant to ampicillin (87%), co-trimoxazole (91%), nalidixic acid (88%) and sensitive to 
nitrofurantoin (52%), cephotaxime (54%) and norfloxacin (71%).  
 





Urinary tract infection represents one of the most 
common diseases encountered in medical practice today 
and occurring from the neonate to the geriatric age group 
(Kunin, 1994; Raju and Tiwari, 2004). The incidence of 
UTI is greater in women as compared to men who may 
be either due to anatomical predisposition or urothelial 
mucosa adherence to the mucopolysaccharide lining or 
other host factors (Schaeffer et al., 2001). Escherichia 
coli is the most frequent urinary tract pathogen isolated 
from 50 to 90% of all uncomplicated urinary tract 
infections as it is present in the gastrointestinal tract and 
provide a pool for initiation of UTI  (Steadman and 
Topley, 1998; Raksha et al., 2003).  
Despite the widespread availability of antibiotics, UTI 
remains the most common bacterial infection in the 
human population (Sharma, 1997). Antibiotic resistance 
may develop in uropathogen due to frequent misuse of 
antibiotics. Antibiotics are usually prescribed empirically 
before the laboratory results of urine culture are available 
(Tambekar and Khandelwal, 2005; Tambekar and 
Dhanorkar, 2005).  To ensure appropriate therapy current 
knowledge of the organisms that cause UTI and there 
antibiotic susceptibility is mandatory (Grubenberg, 1984). 
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also globally and newly introduced pathogens spreading 
rapidly in susceptible host (Gupta et al., 2002). For better 
decision-making physicians needs more information 
about local susceptibility pattern of uropathogens. 
Therefore it was rational approach to do bacteriological 
examination of urine sample along with their antibiogram 




MATERIALS AND METHODS 
 
A total of 174 midstream urine samples were collected in sterile 
containers from suspected urinary tract infected cases. With 
standard calibrated loop delivering 0.01 ml of urine was inoculated 
on Cysteine Lactose Electrolyte Deficient (CLED) agar and 
incubated aerobically at 37°C for 18-24 h. After incubation, if the cfu 
is more than 105, it consider as significant bacteriuria and such 
urine samples further processed for identification and antibiogram 
of bacterial pathogen. But, if the cfu is less than 105, it considers as 
non–significant bacteriuria or negative.   
Identification of bacterial pathogens was made on the basis of 
gram reactions, morphology and biochemical characteristics. 
Isolates were tested for antimicrobial susceptibility by disc diffusion 
technique (Agrawal, 1974) on Muller Hinton agar using the ready-
made antibiotics supplied by Hi-media ltd, Mumbai (Table 1).  
The Multiple Antibiotic Resistance indices (MARI) were 
calculated as follows: MAR index for isolates = [Number of 
antibiotics to which the isolate is resistance / Number of antibiotics 
tested]. While MAR index for an antibiotics = [Number of antibiotics 














A total of 174 urine samples were analyzed for isolation 
and identification of bacterial isolates as per standard 
methods. Out of which 68 samples were found to be 
significant bacteriuria and remaining 106 samples were 
either non-significant bacteriuria or very low bacterial 
count or sterile urine. In present study, out of 68 isolated 
uropathogens the most common isolate was E. coli 
(59%), followed by Pseudomonas aeruginosa (15%), 
Klebsiella pneumoniae (10%), Proteus mirabilis (9%), 
Staphylococcus aureus (6%) and Citrobacter freundii 
(1%). The urinary tract infections were found to most 
frequently in female (63%) than male (37%).   
The multiple antibiotic resistant indices (MARI) 
calculated for E. coli was 0.9, 0.85, 0.52 and 0.38 in one 
each strain, 0.76 in 4 strains, and 0.71 in 3 strains. 0.66 
in 10 strains, 0.61 in 7 strains, 0.57 in 10 strains and 0.47 
in 3 strains.  The MAR indices for Ps. aeruginosa were 
0.95, 0.85, 0.61, 0.14 and 0.04 in 1 each strain, 0.76 in 3 
strains and 0.52 in 2 strains. The MAR indices for Pr. 
mirabilis were 0.9, 0.71, 0.66, 0.57, 0.52 and 0.04 in 1 
each strain and for S. aureus was 0.71 and 0.23 in 1 
each strain and 0.61 in 2 strains. The MAR index for only 
one strain of C. freundii was 0.42 (Table 2). 
All these isolated uropathogens were resistances to 
commonly used antibiotics such as co-trimoxazole 
(91.17%, MARI 0.043), pefloxacin (90%, MARI 0.042), 
nalidixic acid (88%, MARI 0.042), cefdinir (87%, MARI 
0.041), ampicillin (87%, MARI 0.041), novobiocin (84%, 
MARI 0.039), cefixime (84%, MARI 0.039), clarithromycin 
(82%, MARI 0.039), vancomycin (81% MARI 0.038), 
ofloxacin (81%, MARI 0.038), ceftriazone (76%, MARI 
(75%, MARI 0.011), amikacin (79%, MARI 0.009),  
gentamycin (79%, MARI 0.009) and meropenem (82%, 
MARI 0.008) (Table 3). 





























































E1 to E40 = E. coli 
Ps.1 to Ps.10 = Ps. aeruginosa, 
Pm1 to Pm6 = Proteus mirabilis 
K1 to K7 = K. pneumoniae 
S1 to S4 = Staphylococcus aureus 





E. coli was found to be most predominant (59%) urinary 
tract infection in our study; the identical finding (58.8%) 
was  also  reported  by  Inabo  and  Obanibi  (2006).  The 
Antibiotics Quantity Antibiotics Quantity 
Amikacin 30 mcg Gatifloxacin 5 mcg 
Ampicillin 10 mcg Gentamycin 10 mcg 
Cefazolin 30 mcg Meropenem 10mcg 
Cefdinir 5 mcg Nalidixic acid 30 mcg 
Cefixime 5 mcg Nitrofurantoin 300 mcg 
Ceftriazone 30 mcg Norfloxacin 10 mcg 
Cefuroxime 30 mcg Novobiocin 30 mcg 
Cephotaxime 30 mcg Ofloxacin 5 mcg 
Ciprofloxacin 5 mcg Pefloxacin 5 mcg 
Clarithromycin 50 mcg Vancomycin 30 mcg 













































E1 19 2 0.90 E35 14 7 0.66 
E2 14 7 0.6 E36 12 9 0.57 
E3 13 8 0.61 E37 12 8 0.61 
E4 06 15 0.28 E38 13 8 0.61 
E5 15 6 0.71 E39 13 8 0.61 
E6 08 13 0.38 E40 12 9 0.57 
E7 13 8 0.61 Ps1 20 1 0.95 
E8 14 7 0.66 Ps2 01 20 0.04 
E9 16 5 0.76 Ps3 18 3 0.85 
E10 12 9 0.57 Ps4 03 18 0.14 
E11 16 5 0.76 Ps5 16 5 0.76 
E12 10 11 0.47 Ps6 16 5 0.76 
E13 12 9 0.57 Ps7 11 10 0.52 
E14 14 7 0.66 Ps8 11 10 0.52 
E15 16 5 0.76 Ps9 13 8 0.61 
E16 11 10 0.52 Ps1 16 5 0.76 
E17 18 3 0.85 K1 20 1 0.95 
E18 12 9 0.57 K2 03 18 0.14 
E19 15 6 0.71 K3 12 9 0.57 
E20 13 8 0.61 K4 14 7 0.66 
E21 14 7 0.66 K5 11 10 0.52 
E22 10 11 0.47 K6 14 7 0.66 
E23 14 7 0.66 K7 11 10 0.52 
E24 12 9 0.57 Pm1 01 20 0.04 
E25 12 9 0.57 Pm2 19 2 0.90 
E26 14 7 0.66 Pm3 15 6 0.71 
E27 13 8 0.61 Pm4 14 7 0.66 
E28 12 9 0.57 Pm5 11 10 0.52 
E29 16 5 0.76 Pm6 12 9 0.57 
E30 14 7 0.66 S1 13 8 0.61 
E31 10 11 0.47 S2 05 16 0.23 
E32 14 7 0.66 S3 15 6 0.71 
E33 15 6 0.71 S4 13 8 0.61 
 
































































































































































study reported that Ps. aeruginosa and C. freundii were 
15 and 1%, respectively, in urinary tract infection,  as was  
and S. aureus were observed to be 10 and 6%, 
respectively, which are in concordance with UTI 
frequency reported (Hussain et al., 2005). Urinary tract 
infection was frequently caused in female (63%) than 
male (37%), which were also observed by Schaeffer et al. 
(2001).   
Tankhiwale et al. (2004) observed maximum resistant 
to ampicillin (79.6%), co-trimoxazole (82%) and nalidixic 
acid (73.8%). They also reported that nitrofurantoin 
(62%), cephotaxime (58.7%) and norfloxacin (45%), 
constitute the reasonable option for treatment of UTI. In 
present study, uropathogens were resistant to ampicillin 
(87%), co-trimoxazole (91%), nalidixic acid (88%) and 
sensitive to nitrofurantoin (52%), cephotaxime (54%) and 
norfloxacin (71%) (Figure 1). 
Ehinmidu (2003) reported that E. coli, S. aureus and 
Ps. aeruginosa strains were highly sensitive to 
ciprofloxacin and gentamicin and these isolates were 
resistant to ampicillin. The author also reported that MAR 
index of isolated bacteria is greater than 0.2, which 
implies that strains of such bacteria originate from an 
environment where several antibiotics are used.  MAR 
index of isolates in present study indicate large portion of 
bacteria were exposed to the antibiotics showing MAR 
index more than 0.2. Most of isolated uropathogens 
showed multiple antibiotics resistance in this area. It may 
be due to large portion of the bacterial isolate being 
previously exposed to several antibiotics.The present 
study data gives idea about the common trend of 
increased antibiotics resistance of uropathogens in this 
region, which may be due to geographic variation or 
indiscriminate or sublethal use of antibiotic. This data not 
only help in proper treatment of UTI patients but also 
discourage the indiscriminate use of antibiotics and 














Co-trimoxazole 62 6 0.043 
Pefloxacin 61 7 0.042 
Nalidixic acid 60 8 0.042 
Cefdinir 59 9 0.041 
Ampicillin 59 9 0.041 
Novobiocin 57 11 0.039 
Cefixime 57 11 0.039 
Clarithromycin 56 12 0.039 
Vancomycin 55 13 0.038 
Ofloxacin 55 13 0.038 
Ceftriazone 52 15 0.037 
Cefazolin 45 23 0.031 
Nitrofurantoin 33 35 0.023 
Cefuroxime 31 37 0.021 
Cephotaxime 26 42 0.018 
Ciprofloxacin 21 47 0.014 
Norfloxacin 20 48 0.014 
Gatifloxacin 17 51 0.011 
Amikacin 14 54 0.009 
Gentamycin 14 54 0.009 






The data will also help the clinicians to give proper 
treatment and prescription of most sensitive antibiotic to 





Agrawal KC (1974). Antibiotic sensitivity test by disc diffusion method:  
Standardisation and interpretation. Indian J Pathol Bacteriol. 17:149-
59. 
Ehinmidu O (2003). Antibiotics susceptibility patterns of urine bacterial 
isolates in Zaria, Nigeria. Trop J Pharm Res. 2(2): 223-228. 
Grubenberg GN (1984). Antibiotic sensitivities of urinary pathogens. 
1971-1982; Antimicrob Chemotherapy; 14: 17 – 23. 
Gupta V, Yadav A, Joshi RM (2002). Antibiotic resistance pattern in 
uropathogens. Indian J Med Microbiol; 20: 96-98. 
Hussain I, Sangma RA, Agarwal KB (2005). Bacterial etiology of urinary 
tract infections and their antibiogram observed in Asam. J Microb 
world; 7(2); 270-273. 
Inabo HI, Obanibi HBJ (2006). Antimicrobial susceptibility of some 
urinary tract clinical isolates to commonly used antibiotics. Afr. J. 
biotechnol. 5 (5): 487-489.  
Kunin CM (1994). Urinary tract infections in females. Clin Infect Dis; 18: 
1-12. 
Mohanty S, Kapil A, Das BK, Dhawan, B (2003) Antimicrobial resistance 
profile of nosocomial uropathogens in a tertiary care hospital. Ind. J 
Med Sci. 57(4): 148-154.    
Raju CB, Tiwari SC (2004). Urinary tract infection – A suitable 
approach. Lecture notes. J. Ind. Academy of clinical Med. 2 (4): 331-
334.  
Raksha R, Shrinivasa H, Mawcaden RS (2003). Occurrence and 
characterization of uropathogenic Escherichia coli in urinary tract 
infection. Ind J Med Microbiol; 21 (2); 102-107. 
Schaeffer AJ, Rajan N Cao Q, Anderson BE, Pruden DL, Sensibar J, 
Duncan JL (2001). Host pathogenesis in urinary tract infection. Int J 
Antimicrob Agents; 17: 245-251. 
 
 




Sharma SC (1997). Understanding of pathogenic mechanisms in UTIS.  
Ann Natl Acad med Sci; 33(1): 31-8. 
Steadman R, Topley N  (1998). The virulence of Escherichia coli in 
urinary tract, chapter 3 In: Urinary tract infection. 1st ed. Chapman 
and Hall publication, London: 37 – 41.    
Tambekar DH, Dhanorkar DV (2005) The prevalence and antibiogram of potential 
bacterial pathogens in clinical specimens. 46th Annual Conference of Association 
of Microbiologist of India, Department of Microbiology, Osmania University, 
Hyderabad, Dec. 8-10. 
Tambekar DH, Khandelwal VK, (2005). Antibiogram of urinary tract 
pathogens. 46th annual conference of association of Microbiologist of 
India, Osmania University, Hydrabad, Dec. 8-10. 
Tankhiwale SS. Jalgaonkar VS, Atimad S, Hassani U. (2004). 
Evaluation of extended spectrum of beta lactamase in urinary 
isolates. Ind J Med Res.; 120, 553-556. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
